Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.950
-0.010 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
1.957
+0.007 (0.35%)
Pre-market: Apr 29, 2026, 7:08 AM EDT
Palisade Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 326 | 350 | 5 | 5 | 8 | 18 | |
| Market Cap Growth | 10820.00% | 7572.39% | -16.56% | -31.77% | -54.57% | - | |
| Enterprise Value | 193 | 345 | -3 | -9 | -5 | 4 | |
| Last Close Price | 1.95 | 2.35 | 1.65 | 8.85 | 78.00 | 975.00 | |
| PS Ratio | - | - | - | 21.88 | - | - | |
| PB Ratio | 2.40 | 2.71 | 0.61 | 0.48 | 0.64 | 2.40 | |
| P/TBV Ratio | 2.52 | 2.71 | 0.61 | 0.48 | 0.64 | 2.40 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.02 | 0.03 | 0.03 | 0.03 | |
| Net Debt / Equity Ratio | -1.03 | -1.03 | -1.29 | -1.07 | -0.96 | -1.40 | |
| Net Debt / EBITDA Ratio | 7.39 | 7.39 | 0.65 | 0.94 | 0.78 | 0.88 | |
| Net Debt / FCF Ratio | 12.29 | 12.29 | 0.79 | 1.08 | 0.90 | 0.70 | |
| Asset Turnover | - | - | - | 0.02 | - | - | |
| Quick Ratio | 28.83 | 28.83 | 3.04 | 4.87 | 4.59 | 4.26 | |
| Current Ratio | 28.95 | 28.95 | 3.24 | 5.15 | 4.89 | 4.61 | |
| Return on Equity (ROE) | -24.52% | -24.52% | -153.56% | -103.40% | -143.72% | -20012.03% | |
| Return on Assets (ROA) | -15.54% | -15.54% | -74.50% | -53.85% | -67.69% | -94.46% | |
| Return on Capital Employed (ROCE) | -13.90% | -13.90% | -194.40% | -112.00% | -120.10% | -117.20% | |
| Earnings Yield | -5.14% | -4.79% | -316.35% | -224.87% | -177.89% | -150.84% | |
| FCF Yield | -3.32% | -3.10% | -267.16% | -203.61% | -166.78% | -83.72% | |
| Buyback Yield / Dilution | -3830.18% | -3830.18% | -210.62% | -677.03% | -370.85% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.